207.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Insmed Inc Borsa (INSM) Ultime notizie
Insmed Insiders Sell US$54m Of Stock, Possibly Signalling Caution - Yahoo Finance
Why Insmed Incorporated stock appeals to analystsJuly 2025 Update & Entry Point Confirmation Signals - BỘ NỘI VỤ
30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 3 Biotech Stocks - The Motley Fool
Why Insmed Incorporated stock remains resilient2025 Major Catalysts & Smart Swing Trading Techniques - moha.gov.vn
Targets Report: How Insmed Incorporated (IM8N) stock correlates with oil markets2025 Biggest Moves & Technical Entry and Exit Tips - BỘ NỘI VỤ
Does Insmed Incorporated stock trade at a discount to peers2025 Short Interest & Low Drawdown Trading Strategies - BỘ NỘI VỤ
Insider Sell: Elizabeth Anderson Sells 5,000 Shares of Insmed In - GuruFocus
Is EU Approval of First NCFB Therapy Reframing Insmed’s (INSM) Investment Outlook? - Yahoo Finance
Insmed (INSM) Rose Following Drug Approval - Finviz
What Catalysts Are Shaping the New Narrative for Insmed? - Yahoo Finance
Insmed stock hits 52-week high at 208.14 USD By Investing.com - Investing.com Canada
Insmed stock hits 52-week high at 208.14 USD - Investing.com India
Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri - MSN
Trend analysis for Insmed Incorporated this week2025 Buyback Activity & Free Safe Capital Growth Stock Tips - newser.com
INSM: TD Cowen Raises Price Target, Maintains Buy Rating | INSM Stock News - GuruFocus
How Insmed Incorporated (IM8N) stock performs in easing cyclesRate Hike & Daily Stock Trend Reports - newser.com
Will Insmed Incorporated (IM8N) stock recover faster than industryFed Meeting & High Accuracy Swing Entry Alerts - newser.com
Insmed wins first EU approval for non-cystic fibrosis bronchiectasis treatment - MarketScreener
Why Insmed Incorporated (IM8N) stock is listed among top recommendationsPortfolio Performance Report & AI Forecast Swing Trade Picks - newser.com
Will Insmed Incorporated stock benefit from automationIndex Update & Accurate Entry/Exit Alerts - newser.com
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews
Insider Sell: Leo Lee Sells 75,000 Shares of Insmed Inc (INSM) - GuruFocus
Building trade automation scripts for Insmed IncorporatedCPI Data & Proven Capital Preservation Methods - newser.com
Insmed director Anderson sells $1.96 million in stock By Investing.com - Investing.com South Africa
Insmed director Anderson sells $1.96 million in stock - Investing.com
Insmed Says European Commission Approves Brinsupri for Treatment of Non-Cystic Fibrosis Bronchiectasis - MarketScreener
Peering Into Insmed Inc's Recent Short Interest - Benzinga
Insmed (INSM) Gains EU Approval for First NCFB Treatment - GuruFocus
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union - PR Newswire
Insmed (Nasdaq: INSM) BRINSUPRI Wins EU OK After 19.4% NCFB Exacerbation Reduction - Stock Titan
European Commission Approves Insmed's Chronic Lung Disease Treatment - MarketScreener
Insmed at Jefferies London: Transforming into a Multi-Franchise Entity By Investing.com - Investing.com Nigeria
Insmed at Jefferies London: Transforming into a Multi-Franchise Entity - Investing.com
INSM: Brensocatib and TPIP advances fuel growth, with major data and market expansions ahead - TradingView
Transcript : Insmed Incorporated Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 08 - MarketScreener
Here’s What Lifted Insmed Incorporated (INSM) in Q3 - Yahoo Finance
Insmed (INSM) Price Target Increased by 15.76% to 206.22 - Nasdaq
How Insmed Incorporated (IM8N) stock compares with tech leadersJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Insmed (BIT:1INSM) Price Target Increased by 19.33% to 179.30 - Nasdaq
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):